Molecular and Cellular Biology, July 2007, p. 5067-5078, Vol. 27, No. 14
0270-7306/07/$08.00+0 doi:10.1128/MCB.00095-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Department of Biomedical Sciences, College of Medicine, Florida State University, 1115 West Call Street, Tallahassee, Florida 32306
Received 16 January 2007/ Returned for modification 15 February 2007/ Accepted 30 April 2007
|
|
|---|
|
|
|---|
In budding yeast, two signal transduction cascades, the mitotic exit network (MEN) and FEAR (for "Cdc-fourteen early anaphase release") pathways, control mitotic exit by regulating Cdc14 localization (19). The components of the MEN pathway include the protein kinases Cdc5, Cdc15, and Dbf2; a GTPase, Tem1; Cdc14; and a Dbf2 binding protein, Mob1 (11). Tem1 plays a central role in the regulation of MEN. Before anaphase, the spindle pole body (SPB)-localized GTPase Tem1 remains inactive due to its association with Bfa1-Bub2, a GAP complex (12, 21, 35). After one of the SPBs enters the daughter cell, SPB-associated Tem1 encounters its activator, Lte1, which localizes within daughter cells, leading to the activation of the MEN pathway (5). Another layer of regulation is Cdc5-dependent Bfa1 phosphorylation, which frees Tem1 from inhibition by Bfa1-Bub2 (14). The FEAR pathway comprises the Polo kinase Cdc5, the separase Esp1, the kinetochore-associated protein Slk19, and Spo12 (27). As opposed to MEN, which induces Cdc14 release in telophase, FEAR contributes to the release of Cdc14 from the nucleolus during early anaphase. It is believed that the FEAR-dependent initial Cdc14 release promotes activation of the MEN pathway by dephosphorylating Cdc15.
Recent evidence indicates a negative role of protein phosphatase 2A (PP2A) in mitotic exit. In a genetic screen for genes that are toxic to cdc5-1 mutants when overexpressed, CDC55, PPH21, and PPH22, which encode the B-regulatory and catalytic subunits of PP2A, respectively, were identified (36). PP2A mutant cells exhibit Cdc14 release in the presence of nocodazole, a microtubule poison (36, 39). Interestingly, Esp1, a component of the FEAR network, promotes Cdc14 release by inactivating PP2ACdc55. Biochemical evidence indicates that PP2ACdc55 dephosphorylates Net1 and antagonizes its phosphorylation by CDK. Therefore, it is likely that FEAR-dependent inactivation of PP2ACdc55 promotes Net1 phosphorylation and leads to Cdc14 release (3, 22). In addition to the function in mitotic exit, Cdc55 also plays a role in sister chromatid separation (18, 34). We have shown that Cdc55 regulates sister chromatid separation in Pds1-dependent and -independent manners (29).
In response to DNA damage, cells activate DNA damage checkpoints that prevent both anaphase entry and mitotic exit (23). In the budding yeast Saccharomyces cerevisiae, the Mec1 DNA damage checkpoint kinase, a member of the conserved family of phosphatidylinositol 3-kinases, phosphorylates its downstream targets, Chk1 and Rad53, in the presence of DNA damage (23, 24). Activated Chk1 kinase phosphorylates the anaphase inhibitor Pds1 and prevents its degradation (33). It is well documented that Pds1 blocks anaphase entry by inhibiting the separase Esp1, which cleaves the cohesin Scc1 and leads to sister chromatid separation (9, 30). In the presence of DNA damage, chk1
mutants form minicolonies, indicating that the cells are able to exit mitosis. It has been shown that Clb2, the mitotic cyclin of budding yeast, is stable in cells that overproduce nondegradable Pds1 (10). Also, the failure of Pds1 degradation prevents both Clb2 degradation and Cdc14 release (25). Furthermore, PDS1 overexpression blocks Net1 phosphorylation, which is required for the dissociation of Cdc14 from Net1, suggesting a negative role of Pds1 in mitotic exit (28). Thus, it is believed that the Chk1-Pds1 pathway controls mitotic exit through Esp1, a component of the FEAR pathway.
It is believed that the Rad53 kinase plays a more important role in preventing mitotic exit, as Clb2 protein levels decrease rapidly in rad53 mutant cells in the presence of DNA damage. Interestingly, cdc5-1 mutants block the anaphase entry of rad53 mutants in the presence of DNA damage (23), raising the possibility that Cdc5 is the target of the Rad53-dependent checkpoint. However, Cdc5 kinase activity has been demonstrated to be high in DNA damage-arrested cells (8). Moreover, Bfa1, a substrate of Cdc5, is phosphorylated in DNA damage-arrested cells, which argues against the role of Cdc5 as a target of DNA damage checkpoints.
Here, we have investigated the role of DNA damage checkpoint components in preventing mitotic exit. Chk1, Pds1, Rad53, and Dun1 are all required for the nucleolar localization of Cdc14 in DNA damage-arrested yeast cells. Moreover, PP2A and Bfa1, the negative regulators of FEAR and MEN, are also required to prevent mitotic exit in the presence of DNA damage. Rad53 and Dun1 may negatively regulate the MEN pathway in a Cdc5-independent manner. However, the loss of function of Rad53 or Dun1 alleviates inhibition of the MEN pathway by Bfa1. The presence of Chk1, Pds1, or PP2A prevents Net1 phosphorylation and subsequent Cdc14 release in the presence of DNA damage. Therefore, inactivation of both the MEN and FEAR pathways by DNA damage checkpoints contributes to the block of mitotic exit.
|
|
|---|
-factor was added to the cell culture. After 2 h of incubation, the G1-arrested cells were washed twice with water and then released into YPD medium to start the cell cycle. |
View this table: [in a new window] |
TABLE 1. Strains used in this study
|
Protein techniques. For protein immunoprecipitation, 50 ml of cells were harvested and protein extracts were prepared with radioimmunoprecipitation assay (RIPA) buffer supplied with protease and phosphatase inhibitors (37). After incubation with antihemagglutinin (anti-HA) antibody (Covance Research Products, Inc.) at 4°C for 1.5 h, protein A/G plus agarose beads (Santa Cruz Biotechnology, Inc.) were added and the mixture was incubated for 1.5 h at 4°C. After three washes with RIPA buffer, the precipitates were resuspended in equal volumes (20 µl) of RIPA buffer and sodium dodecyl sulfate (SDS) protein-loading buffer. The samples were then boiled for 5 min and resolved with an 8% SDS-polyacrylamide gel. Proteins were detected by enhanced chemiluminescence (Perkin Elmer LAS, Inc.) after being probed with primary antibody (anti-Myc or anti-HA antibodies; Covance Research Products, Inc.) and horseradish peroxidase-conjugated secondary antibody (Jackson ImmunoResearch, Inc.).
|
|
|---|
mutants, some cdc13-1 pds1-m9 mutant cells were able to form microcolonies. Mutations in Cdc55 and Bfa1, the negative regulators of the FEAR and MEN pathways, respectively, also lead to microcolony formation. The ability to form microcolonies in the presence of DNA damage indicates that mutations in Chk1, Pds1, Cdc55, Rad53, Dun1, and Bfa1 allow both anaphase entry and mitotic exit.
![]() View larger version (23K): [in a new window] |
FIG. 1. DNA damage checkpoint genes are required for mitotic arrest. (A) Microcolony formation of cdc13-1 single and double mutant cells. Cells with the indicated genotypes were grown at 25°C in YPD to mid-log phase and then plated onto prewarmed YPD plates and incubated at 37°C. After 8 h of incubation, the growth of cells was examined under a microscope. Percentages of cells that formed microcolonies (more than four cells) are shown. The growth of representative cells on YPD plates is shown on the right. (B) Spindle morphology of cdc13-1 single and double mutants. TUB1-GFP strains with the indicated genotypes were arrested in G1 phase with -factor at 25°C and then released into YPD medium and incubated at 34°C. The spindle morphology was examined under a fluorescence microscope, and percentages of cells with a short spindle structure are shown. The spindle morphology of some cells after 4 h of incubation is shown on the right. (C) Budding index of cdc13-1 single and double mutants. Cells with the indicated genotype were G1 arrested and then sonicated before being released into the cell cycle at 34°C. The percentages of rebudded cells are shown at the top, and representative cells are shown at the bottom.
|
A new bud appears after a yeast cell initiates a new round of the cell cycle. Thus, we examined the rebudding process of DNA damage checkpoint mutants in cdc13-1-arrested cells. After incubation of cdc13-1 single mutant cells at 34°C for 4 h, almost all of them were arrested as large budded cells. In contrast, DNA damage checkpoint mutant cells began to rebud after 2.5 h incubation at 34°C (Fig. 1C). Together, the microcolony formation, spindle morphology, and rebudding phenotypes suggest that DNA damage checkpoint genes are required to prevent anaphase entry and mitotic exit in the presence of DNA damage.
Intact DNA damage checkpoints prevent premature Cdc14 release from the nucleolus.
The activation of mitotic exit pathways is marked by the release of phosphatase Cdc14 from the nucleolus (27, 32). Hence, we further examined the localization of Cdc14 in various mutants by using a strain with 5-GFP-tagged Cdc14 (40). cdc13-1 single and double mutants containing Cdc14-5-GFP were synchronized at G1 phase and then released into 34°C medium. Almost all of the cdc13-1 single mutant cells showed nucleolar localization of Cdc14, suggesting that the presence of DNA damage inhibits Cdc14 release from the nucleolus. However, some rad53-21, dun1
, chk1
, and pds1-m9 mutant cells were unable to sequester Cdc14 within the nucleolus when Cdc13 is inactivated (Fig. 2A and B). Among them, cdc13-1 rad53-21 mutants exhibited the most dramatic phenotype. More than 40% of cdc13-1 rad53-21 double mutant cells exhibited released Cdc14 after 2 h of incubation at 34°C. All of these observations suggest that the DNA damage checkpoint components Rad53, Dun1, Chk1, and Pds1 are required to prevent mitotic exit in the presence of DNA damage.
![]() View larger version (27K): [in a new window] |
FIG. 2. DNA damage checkpoint genes are required to prevent Cdc14 release from the nucleolus in response to DNA damage. cdc13-1 single and double mutants cells with the indicated genotype carrying a Cdc14-5-GFP fusion were arrested in G1 and then released into fresh YPD medium at 34°C. Cells were collected and fixed with 3.7% formaldehyde at the indicated time points for microscopic examination. Budding index (A) and Cdc14 release kinetics (B) in two groups of DNA damage checkpoint mutants are shown. The localization of Cdc14 in cdc13-1 and cdc13-1 cdc55 cells at 120 min is shown at the bottom of panel A.
|
and cdc13-1 bfa1
mutants. After 2 h of incubation at 34°C, 63% of cdc13-1 cdc55
and 31% of cdc13-1 bfa1
mutant cells showed released Cdc14 (Fig. 2A and B). Consistently, more cdc13-1 cdc55
cells than cdc13-1 bfa1
cells rebudded. Therefore, the intact DNA damage checkpoint and the negative regulators of FEAR and MEN are all required to prevent mitotic exit in response to DNA damage.
Two parallel DNA damage checkpoint pathways control mitotic exit.
In budding yeast, Chk1, Pds1, Rad53, and Dun1 define two parallel checkpoint pathways that control anaphase entry (13, 23). We have shown that mutation in any of the genes allows cdc13-1 mutant cells to exit mitosis and rebud when incubated at 34°C. It is also possible that these checkpoint genes control mitotic exit with distinct mechanisms. To test this, we performed epistasis analysis of DNA damage checkpoint mutants for the mitotic exit process. rad53-21 dun1
double mutants did not exhibit an additive mitotic exit phenotype in cdc13-1-arrested cells, based on rebudding kinetics, when cells were arrested with cdc13-1. A chk1
pds1-m9 double mutant strain exhibited rebudding kinetics similar to those of either single mutant. In contrast, more rad53-21 chk1
double mutant cells rebudded than did either single mutant (Fig. 3A). Therefore, the Chk1-Pds1 checkpoint acts in parallel to Rad53-Dun1 to prevent mitotic exit in the presence of DNA damage.
![]() View larger version (22K): [in a new window] |
FIG. 3. Epistasis analysis of DNA damage checkpoint mutants in mitotic exit regulation. (A) cdc13-1 single and double mutants with the indicated genotypes were arrested in G1 phase and then released into 34°C medium. The percentage of rebudded cells was counted over time. (B) pds1-m9 and dun1 mutants show additive mitotic exit in cdc13-1-arrested cells. G1-synchronized cells were released into 34°C medium. The upper panel shows the budding index and the kinetics of Cdc14 release. Microcolony formation of mutant cells with the indicated genotypes is shown in the lower panel.
|
mutants also exhibit arrest defects in response to DNA damage, we examined whether Cdc55 functions in the same pathway as either Chk1 or Rad53. A cdc55
chk1
double mutant did not exhibit a more dramatic mitotic exit phenotype than did a cdc55
single mutant. In contrast, rad53-21 cdc55
double mutant cells exhibited a more dramatic rebudding phenotype than either single mutant when arrested with cdc13-1 (Fig. 3A), suggesting that Chk1, Pds1, and Cdc55 act in the same pathway to control mitotic exit in response to DNA damage.
We also compared Cdc14 release kinetics in pds1-m9 and dun1
single mutants and pds1-m9 dun1
double mutants in the presence of DNA damage. Obviously, more cdc13-1 pds1-m9 dun1
mutant cells exhibited released Cdc14 than did either single mutant. At 90 min after G1 release, 38% of double mutant cells showed released Cdc14, whereas only 15% of cdc13-1 pds1-m9 and 18% of cdc13-1 dun1
cells exhibited released Cdc14. Also, fewer cdc13-1 pds1-m9 dun1
cells were able to maintain cell cycle arrest, as judged by the more dramatic decrease in large budded cells, than was either single mutant. Moreover, loss of function of both Pds1 and Dun1 resulted in more efficient microcolony formation (Fig. 3B). All of these observations support the conclusion that two DNA damage checkpoint pathways, Chk1-Pds1-PP2A and Rad53-Dun1, control mitotic exit in response to DNA damage.
Chk1 kinase regulates Cdc14 release by inhibiting the FEAR pathway.
In response to DNA damage, Chk1 prevents anaphase entry by stabilizing the anaphase inhibitor Pds1 (23). Our observations indicate that Chk1-dependent Pds1 phosphorylation also plays a role in preventing mitotic exit. Stabilized Pds1 prevents anaphase entry by binding to the separase Esp1 (9). It has been shown that Esp1 facilitates mitotic exit by promoting the phosphorylation of Net1 and that mutation of the phosphorylation sites of Net1 abolishes Esp1-induced mitotic exit (3, 22). Therefore, we tested whether mutations of the Net1 phosphorylation sites are also able to abolish the premature mitotic exit phenotype in chk1 and pds1 mutants. We compared cell cycle progression in cdc13-1, cdc13-1 chk1
, and cdc13-1 chk1
net1-6Cdk mutants incubated at the restrictive temperature. Strikingly, the net1-6Cdk mutation, in which six Cdk1 phosphorylation sites were mutated to alanine, suppressed cell division, Cdc14 release, and microcolony formation in cdc13-1 chk1
mutants (Fig. 4A and C). The net1-6Cdk mutation also inhibited premature mitotic exit in cdc13-1 pds1-m9 mutants (F. Liang, unpublished data). It has been shown that the net1-6Cdk mutation delays, but does not block, Cdc14 release (3). The observation that the net1-6Cdk1 mutation blocks Cdc14 release and microcolony formation is presumably due to the inhibition of the MEN pathway in cdc13-1-arrested chk1
mutants. Thus, we conclude that Chk1 and Pds1 negatively regulate mitotic exit by preventing the phosphorylation of Net1.
![]() View larger version (27K): [in a new window] |
FIG. 4. Activated Chk1 kinase inhibits Cdc14 release by preventing Net1 phosphorylation. (A) net1-6Cdk mutants suppress Cdc14 release in cdc13-1 chk1 mutant cells. Cells with the indicated genotypes were arrested in G1 at 25°C and then released into 34°C medium. Cells were collected every 30 min and fixed with formaldehyde. The budding index and the percentage of cells with released Cdc14 were determined. (B) Suppression of cell cycle progression in cdc13-1 chk1 mutants by cdc15-2. Cells with the indicated genotypes were treated as described for panel A. (C) Both net1-6Cdk and cdc15-2 mutants suppress microcolony formation in cdc13-1 chk1 cells. Mid-log-phase cells with the indicated genotypes were plated onto YPD plates and incubated at 37°C for 8 h before the formation of microcolonies was examined.
|
mutants depends on the MEN pathway, a cdc13-1 chk1
cdc15-2 mutant was constructed. Cdc15 kinase is a component of the MEN pathway, and cdc15-2 cells arrest at telophase when incubated at the nonpermissive temperature (4). To our surprise, introduction of the cdc15-2 mutation suppressed cell division and microcolony formation of cdc13-1 chk1
mutants but failed to prevent Cdc14 release (Fig. 4B and C). After the cells were released into 34°C medium from G1 arrest for 2 h, 24% of cdc13-1 chk1
and 18% of cdc13-1 chk1
cdc15-2 mutant cells exhibited released Cdc14 (Fig. 4B). We conclude that Chk1 prevents Cdc14 release independently of MEN, but MEN activation is indispensable for mitotic exit.
The net1-6Cdk mutation blocks mitotic exit in cdc13-1 cdc55
cells.
More than 60% of cdc13-1 cdc55
double mutant cells exhibited released Cdc14 after incubation at the nonpermissive temperature (Fig. 2A). Because PP2ACdc55 negatively regulates mitotic exit by dephosphorylating Net1 (22), the hyperphosphorylation of Net1 may contribute to premature Cdc14 release in DNA damage-arrested cdc55
mutant cells. To test this possibility, we compared the cell cycle progression, microcolony formation, and Cdc14 release in cdc13-1, cdc13-1 cdc55
, and cdc13-1 cdc55
net1-6Cdk mutant cells. For some unknown reason, cdc13-1 cdc55
net1-6Cdk cells were not efficiently arrested at 34°C; thus, the experiment was carried out at 37°C. The net1-6Cdk mutation not only blocked Cdc14 release but also suppressed microcolony formation in cdc13-1 cdc55
mutants (Fig. 5A and C), indicating that premature mitotic exit in cdc13-1 cdc55
mutant cells depends on Net1 phosphorylation.
![]() View larger version (30K): [in a new window] |
FIG. 5. The net1-6Cdk mutation suppresses Cdc14 release in cdc55 mutant cells. (A) The net1-6Cdk mutation restores the nucleolar localization of Cdc14 in cdc13-1 cdc55 cells. Cells in mid-log phase were arrested at G1 phase and then released into 37°C YPD medium. Cells were harvested and fixed with 3.7% formaldehyde at 30-min intervals to count the budding index and examine Cdc14 localization. The percentages of large budded cells and cells with released Cdc14 are shown. (B) The cdc15-2 mutation failed to restore the nucleolar localization of Cdc14 in cdc13-1 cdc55 cells. G1-arrested cells were released into 34°C medium and collected every 30 min to examine budding and Cdc14 localization. (C) Microcolony formation of cdc55 mutant cells in the presence of DNA damage. Cells with the indicated genotypes were spread onto 37°C YPD plates. The percentage of cells that formed microcolonies was determined after 8 h incubation.
|
mutants in the presence of nocodazole, a microtubule-depolymerizing drug (36). Thus, we analyzed the effect of cdc15-2 mutants on the mitotic exit of cdc13-1 cdc55
mutants. Interestingly, cdc15-2 did not show any suppression of Cdc14 release in cdc13-1 cdc55
mutants. In contrast, the suppression of microcolony formation by cdc15-2 was dramatic, although not complete (Fig. 5B and C). Therefore, the released Cdc14 in cdc13-1 cdc55
cdc15-2 mutants is not sufficient to trigger mitotic exit. Taken together, net1-6Cdk mutants suppress both Cdc14 release and mitotic exit in chk1, pds1, and cdc55 mutants in the presence of DNA damage. Inactivation of MEN by the cdc15-2 mutant fails to restore the nucleolar localization of Cdc14 in the above mutants but is able to suppress cell cycle progression, further confirming the notion that FEAR-induced Cdc14 release promotes mitotic exit by activating the MEN pathway (27). Rad53 regulates mitotic exit through the MEN pathway. Previous data indicate that Rad53 plays a major role in preventing mitotic exit in response to DNA damage (23). To address whether Rad53 inhibits mitotic exit through the FEAR or MEN pathway, we examined the mitotic exit process in cdc13-1 rad53-21 mutant cells with dysfunctional FEAR or MEN. For this purpose, cdc13-1 rad53-21 net1-6Cdk CDC14-5-GFP and cdc13-1 rad53-21 cdc15-2 CDC14-5-GFP strains were generated. G1-arrested cells were released into 34°C YPD medium and then collected for budding index and Cdc14 localization analyses. cdc15-2 almost completely suppressed cell division and Cdc14 release in cdc13-1 rad53-21 cells (Fig. 6B). Also, very few cdc13-1 rad53-21 cdc15-2 cells formed microcolonies after incubation on 37°C plates (Fig. 6C), indicating that the premature mitotic exit in rad53-21 mutants can be suppressed by inactivation of the MEN pathway. In contrast, net1-6Cdk delayed but failed to block cell division and Cdc14 release in cdc13-1 rad53-21 cells (Fig. 6A). Moreover, most cdc13-1 rad53-21 net1-6Cdk mutant cells were able to form microcolonies on 37°C plates (Fig. 6C). The data suggest that MEN, but not FEAR, is likely the target of Rad53.
![]() View larger version (24K): [in a new window] |
FIG. 6. Rad53 regulates mitotic exit through the MEN pathway. (A) The net1-6Cdk mutation fails to suppress mitotic exit in cdc13-1 rad53-21 cells. Cells with the indicated genotypes were treated as described in the legend to Fig. 4. The percentages of large budded cells and cells with released Cdc14 are shown. (B) The cdc15-2 mutation suppresses mitotic exit in cdc13-1 rad53-21 mutants. Cells were treated as described in the legend to Fig. 4, and the percentages of large budded cells and cells with released Cdc14 are shown. (C) Microcolony formation of rad53-21 mutant cells in the presence of DNA damage. Cells with the indicated genotypes were spread onto 37°C YPD plates and treated as described.
|
![]() View larger version (21K): [in a new window] |
FIG. 7. Rad53 regulates Cdc14 release independently of Cdc5. (A) The cdc5-2 mutation delays anaphase entry in cdc13-1 rd53-21 cells. Cells with the indicated genotypes were arrested at G1 phase with -factor at 25°C and then released into 34°C YPD medium. Cells were collected every 30 min and fixed for DAPI staining. The percentages of cells with segregated nuclei are shown. The right panel shows the nuclear morphology of cells at 180 min. (B) The cdc5-2 mutation fails to block Cdc14 release in cdc13-1 rad53-21 mutant cells. G1-arrested cells with the indicated genotypes were released into 34°C YPD medium for the analysis of budding index and Cdc14 localization. The bottom panel shows the localization of Cdc14-GFP in cells collected at 120 min. (C) The rad53-21 mutation partially suppresses the mitotic exit defects in cdc5-1 mutants. G1-arrested cdc5-1 and cdc5-1 rad53-21 mutant cells with 5-GFP-tagged Cdc14 were released into 37°C YPD medium. Cells were collected every 30 min for the analysis of budding index and Cdc14 localization.
|
mutants (Fig. 8B). Therefore, activated Rad53-Dun1 might be required to maintain or facilitate Bfa1-Tem1 interaction. Given the fact that Dun1 is a substrate of Rad53 kinase (41), Dun1 may play a more direct role in regulating Bfa1-Tem1 interaction. As we found that rad53 mutants can partially suppress the Cdc14 release defects in cdc5-1 mutants in the absence of DNA damage (Fig. 7C), it is possible that Rad53-Dun1 also regulates Bfa1-Tem1 interaction during the normal cell cycle.
![]() View larger version (19K): [in a new window] |
FIG. 8. (A) Bfa1-Tem1 interaction is decreased in rad53-21 mutants in the presence of DNA damage. Cells with the indicated genotypes were arrested in G1 phase at 25°C and then released into the cell cycle at 34°C. After incubation for 1, 2, and 3 h, protein extracts from 50 ml of cells were prepared and used for immunoprecipitation analysis with anti-HA antibody. Bfa1-myc and Tem1-HA levels were analyzed after Western blotting. (B) Bfa1-Tem1 interaction is decreased in dun1 mutants in the presence of DNA damage. The same protocol was used to examine the interaction between Bfa1 and Tem1 in the presence or absence of Dun1. (C) Model for the regulation of mitotic exit by DNA damage checkpoints.
|
|
|
|---|
Rad53 kinase phosphorylates Dun1 directly and is responsible for the activation of Dun1 (6, 7, 15). As both Rad53 and Dun1 negatively regulate mitotic exit and Dun1 acts downstream of Rad53, we reason that Dun1 plays a more direct role in regulating MEN. Our previous data indicate that Bfa1 exhibits a Rad53- and Dun1-dependent, but Chk1-independent, band shift in response to DNA damage (14). Thus, one possibility is that Dun1 kinase phosphorylates Bfa1 and prevents the dissociation of Bfa1 from Tem1. To support this, we observed decreased Bfa1-Tem1 association in rad53-21 and dun1
mutants in the presence of DNA damage. Further experiments are required to test this possibility in detail.
If Rad53 regulates mitotic exit through Dun1, why do cdc13-1 rad53-21 mutant cells exhibit a more dramatic checkpoint defect than cdc13-1 dun
1 mutant cells? One possibility is that Rad53 kinase negatively regulates mitotic exit through other pathways. For example, it has been shown that Rad53 also phosphorylates Pds1 and prevents its association with the degradation machinery (1). Thus, activated Rad53 kinase may prevent mitotic exit through both Dun1 and Pds1.
In response to DNA damage, Chk1 phosphorylates and stabilizes Pds1, which binds to the separase Esp1 and prevents anaphase entry (23, 33). Here we have demonstrated that Chk1 and Pds1 are also required to prevent mitotic exit in DNA damage-arrested cells. Mutations of the CDK phosphorylation sites on Net1 (net1-6Cdk) prevent mitotic exit in cdc13-1 chk1
and cdc13-1 pds1-m9 mutants. As Esp1 promotes mitotic exit by facilitating Net1 phosphorylation (22), the negative role of the Chk1-Pds1 DNA damage checkpoint in mitotic exit is to prevent Net1 phosphorylation by inhibiting Esp1.
Cdc55, the B-regulatory subunit of PP2A, is also shown to be required for efficient mitotic arrest in response to DNA damage. Like chk1 and pds1 mutants, net1-6Cdk also suppressed Cdc14 release and advanced cell cycle progression in cdc13-1 cdc55
mutants, supporting the notion that PP2ACdc55 dephosphorylates Net1 and prevents Cdc14 release (22). All of these observations suggest that Chk1, Pds1, and Cdc55 function in the same pathway and that the Chk1-Pds1 checkpoint negatively regulates mitotic exit by preventing the inactivation of PP2ACdc55.
An interesting observation is that the cdc15-2 mutant suppresses the cell division of chk1
, pds1-m9, and cdc55
mutants but fails to block Cdc14 release in these mutants in the presence of DNA damage. Strikingly, cdc13-1 cdc55
cdc15-2 cells failed to exit mitosis, although more than 60% of the mutant cells exhibited released Cdc14 (Fig. 5B and C). A similar observation has been made with metaphase-arrested cdc15-2 cdc55
mutant cells (22, 39). Why is the released Cdc14 in these cells unable to promote mitotic exit? It is likely that the role of FEAR in mitotic exit is to activate the MEN pathway. Consistent with this notion, it has been shown that FEAR pathway-dependent Cdc14 release leads to dephosphorylation of Cdc15, which may promote MEN activation (27). In cdc15 mutant-arrested cells, a FEAR pathway-dependent transient Cdc14 release was observed (27); why, then, is Cdc14 not resequestered into the nucleolus in cdc55
mutants in the presence of DNA damage? Our result reveals relatively high levels of Clb2 in cdc13-1 cdc55
mutant cells (Liang, unpublished data), raising the possibility that active Clb2-Cdk1 may prevent the resequestering of Cdc14. However, overexpression of Sic1, the Cdk1 inhibitor, failed to induce Cdc14 nucleolar localization (Liang, unpublished data). Thus, an unidentified mechanism contributes to the redistribution of Cdc14 after FEAR-induced Cdc14 release.
In summary, our data indicate that yeast cells prevent mitotic exit by inhibiting both the FEAR and MEN pathways in response to DNA damage (Fig. 8C). The activated Chk1-Pds1 pathway inhibits Cdc14 release by preventing Esp1-dependent inactivation of PP2ACdc55. In contrast, Rad53-Dun1 may directly regulate MEN by preventing the dissociation of Bfa1 from Tem1 in a Cdc5-independent manner. Together, activated Chk1-Pds1 and Rad53-Dun1 checkpoint proteins keep the FEAR and MEN pathways inactive in response to DNA damage.
This work was supported by an American Heart Association Scientist Development grant and by a grant from the James and Esther King Biomedical Research Program (04NIR13) from the Florida State Department of Health to Y.W.
Published ahead of print on 7 May 2007. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»